Skip to content
Lower risk Medical device recall · FDA · Published May 13, 2022

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Test Strips May Give False Negatives

NeuMoDx recalls Flu A-B/RSV/SARS-CoV-2 Vantage Test Strips (Model 300900) due to potential false negatives in certain samples, which could lead to undetected infections and delayed treatment.

🇺🇸 FDA recall #Z-1251-2022Medical deviceNeuMoDx ›
Take action

Contact the company

Recalling firmNeuMoDx Molecular Inc1250 Eisenhower Pl · Ann Arbor, MI 48108-3281
✎ GovInfoNow plain-language explainer

NeuMoDx is recalling Flu A-B/RSV/SARS-CoV-2 Vantage Test Strips (Model 300900) because they might give false negative results for some infections. This could mean people don't know they're infected and might spread illness or delay treatment. Read more at govinfonow.com/recall/60705-neumodx-flu-a-b-rsv-sars-cov-2-test-strips.

Source Summary by GovInfoNow · govinfonow.com/recall/60705-neumodx-flu-a-b-rsv-sars-cov-2-test-strips · Updated August 10, 2026 · FDA enforcement record: FDA #Z-1251-2022

Cite this page

“NeuMoDx Flu A-B/RSV/SARS-CoV-2 Test Strips May Give False Negatives.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/60705-neumodx-flu-a-b-rsv-sars-cov-2-test-strips. Based on FDA recall #Z-1251-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1251-2022%22&limit=1).

The FDA announced on May 13, 2022, that NeuMoDx Molecular Inc is recalling the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900. The agency cited a potential for reduced analytical sensitivity that may lead to false negative results.

How to tell if you have it

  • Brand: NeuMoDx
  • Product: NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip
  • Model No.: 300900
  • UDI-DI (GTIN): 10814278020830
  • Lot numbers: 111915 - 117508

The hazard

There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.

Context

GovInfoNow's records show NeuMoDx Molecular Inc has issued five other recalls since May 4, 2021. Other recent recalls of similar products include Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025), S. Typhi/Para Ty: False Test Results Risk from Unapproved Diagnostic Strips (Nov. 22, 2025), and Meridian Bioscience Revogene C. difficile Test Recall (Dec. 5, 2025).

How to tell if you have this one

Check for the model number 300900 on the test strip packaging. The product was sold with lot numbers 111915 to 117508.

  • Brand
    NeuMoDx
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Test Strip Model

    Look for the model number 300900 on the test strip packaging to confirm if it's recalled.

Where it went and when

Where it was distributed

Distributed in 8 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: yesPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: yesVAMaryland: yesMDDelaware: not listedDEArizona: not listedAZNew Mexico: yesNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida, Maryland, Michigan, New Mexico, New York, Pennsylvania, Tennessee, Virginia.

Recall timeline

FDA published this recall 33 days after the firm started it.

1. Firm started the recall: May 13, 202212. FDA classified it Class II: Jun 8, 202223. Published in FDA’s Enforcement Report: Jun 15, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1251-2022 (May 13, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1251-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA